Zegers-Hochschild Fernando, Crosby Javier A, Musri Carolina, Borges de Souza Maria do Carmo, Martinez A Gustavo, Amaral Silva Adelino, Mojarra José María, Masoli Diego, Posada Natalia
Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile; Program of Ethics and Public Policies in Human Reproduction, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.
Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.
Reprod Biomed Online. 2022 Aug;45(2):235-245. doi: 10.1016/j.rbmo.2022.02.026. Epub 2022 Mar 12.
What was the utilization, effectiveness and safety of assisted reproductive technology (ART) in Latin America during 2019?
This was a retrospective collection of multinational data on ART performed at 196 institutions from 15 countries.
A total of 106,918 initiated cycles, 18,133 deliveries and 21,096 births were reported. ART utilization was 24-558 cycles per million inhabitants. Women aged ≥40 years represented 32.9% of fresh IVF and intracytoplasmic sperm injection (ICSI) cycles. After removing freeze-all cycles, the delivery rate per oocyte retrieval was 17.3% for ICSI and 19.5% for IVF. Overall, single-embryo transfer (SET) represented 36.2% of fresh transfers, with a 19.5% delivery rate per transfer, increasing to 30.7% for elective SET and 32.7% for blastocyst elective SET (eSET). The delivery rate for double-embryo transfers (DET) was 27.8%, increasing to 37.1% after elective DET. This 6.4% increment in deliveries between eSET and elective DET resulted in a 12-fold increase in twin births. Furthermore, overall perinatal mortality was more than two-fold higher for twin compared with singleton deliveries. The delivery rate for frozen-thawed SET reached 28.1%, most being blastocyst transfers. Of all births, 72.3% were singletons, 26.4% twins and 1.3% triplets and higher multiples. Preterm deliveries reached 14.3% for singletons and 58.1% for twins. Perinatal mortality was 7.4‰ in singletons, 17.2‰ for twins and 62.9‰ for triplets or higher.
The number of initiated cycles has slowly increased in countries with laws or regulations facilitating access. FET cycles predominate and blastocyst SET are also increasing. The data show that, especially in young women and oocyte recipients, when there is more than one blastocyst for transfer, eSET should be the rule.
2019年拉丁美洲辅助生殖技术(ART)的使用情况、有效性和安全性如何?
这是一项对来自15个国家196家机构的ART跨国数据进行的回顾性收集。
共报告了106,918个起始周期、18,133例分娩和21,096例出生。ART的使用量为每百万居民24 - 558个周期。40岁及以上女性占新鲜体外受精(IVF)和卵胞浆内单精子注射(ICSI)周期的32.9%。去除所有冷冻周期后,ICSI每次取卵的分娩率为17.3%,IVF为19.5%。总体而言,单胚胎移植(SET)占新鲜移植的36.2%,每次移植的分娩率为19.5%,选择性SET的分娩率增至30.7%,囊胚选择性SET(eSET)为32.7%。双胚胎移植(DET)的分娩率为27.8%,选择性DET后增至37.1%。eSET和选择性DET之间分娩率6.4%的增幅导致双胎分娩增加了12倍。此外,双胎围产期死亡率比单胎分娩高出两倍多。冻融SET的分娩率达到28.1%,大多数是囊胚移植。在所有出生中,72.3%为单胎,26.4%为双胎,1.3%为三胎及以上多胎。单胎早产率为14.3%,双胎为58.1%。单胎围产期死亡率为7.4‰,双胎为17.2‰,三胎及以上为62.9‰。
在有法律法规便利获取的国家,起始周期数已缓慢增加。冷冻胚胎移植(FET)周期占主导,囊胚SET也在增加。数据表明,特别是在年轻女性和卵母细胞受者中,当有多个囊胚可供移植时,eSET应成为常规做法。